Phenotypes | Crohn’s disease | Ulcerative colitis | ||||||
---|---|---|---|---|---|---|---|---|
ORIVW (95% CI) | PIVW | Pheterogeneity | Ppleiotropy | ORIVW (95% CI) | PIVW | Pheterogeneity | Ppleiotropy | |
Respiratory system | ||||||||
 Larynx | 0.928 (0.799, 1.077) | 0.090 | 0.046 | 0.051 | 1.025 (0.861, 1.220) | 0.779 | 0.064 | 0.062 |
 Bronchus and lung | 0.997 (0.954, 1.042) | 0.900 | 0.012 | 0.013 | 1.036 (0.985, 1.090) | 0.167 | 0.270 | 0.281 |
Oral cavity and pharynx | ||||||||
 Oral cavity | 1.112 (1.008, 1.227) | 0.034 | 0.111 | 0.135 | 1.158 (1.041, 1.288) | 0.007 | 0.487 | 0.455 |
 Pharynx | 1.019 (0.927, 1.121) | 0.696 | 0.847 | 0.840 | 1.035 (0.924, 1.159) | 0.553 | 0.371 | 0.367 |
Digestive system cancer | ||||||||
 Esophagus | 0.982 (0.917, 1.050) | 0.589 | 0.506 | 0.502 | 0.986 (0.906, 1.074) | 0.752 | 0.973 | 0.973 |
 Small intestine | 1.037 (0.892, 1.205) | 0.640 | 0.018 | 0.015 | 1.124 (0.949, 1.332) | 0.175 | 0.486 | 0.490 |
 Stomach | 0.997 (0.924, 1.076) | 0.939 | 0.507 | 0.488 | 0.951 (0.864, 1.046) | 0.303 | 0.590 | 0.591 |
 Pancreas | 0.977 (0.910, 1.047) | 0.506 | 0.360 | 0.359 | 1.020 (0.932, 1.116) | 0.671 | 0.272 | 0.257 |
 Hepatocellular | 0.949 (0.785, 1.147) | 0.586 | 0.387 | 0.366 | 0.908 (0.714, 1.155) | 0.432 | 0.289 | 0.302 |
 Hepatic bile duct | 1.170 (0.948, 1.444) | 0.144 | 0.257 | 0.285 | 1.020 (0.792, 1.313) | 0.879 | 0.634 | 0.668 |
 Extrahepatic bile duct | 0.964 (0.831, 1.118) | 0.626 | 0.687 | 0.672 | 0.928 (0.772, 1.116) | 0.428 | 0.792 | 0.774 |
Hematologic malignancy | ||||||||
 Multiple myeloma | 0.969 (0.894, 1.051) | 0.449 | 0.137 | 0.141 | 0.983 (0.885, 1.091) | 0.749 | 0.094 | 0.102 |
 Hodgkin lymphoma | 0.990 (0.877, 1.117) | 0.867 | 0.669 | 0.673 | 0.965 (0.820, 1.136) | 0.672 | 0.154 | 0.175 |
 Non-Hodgkin lymphoma | 1.010 (0.958, 1.065) | 0.709 |  < 0.001 |  < 0.001 | 1.058 (0.987, 1.134) | 0.110 |  < 0.001 |  < 0.001 |
 Acute myelocytic leukemia | 0.930 (0.838, 1.032) | 0.170 | 0.524 | 0.508 | 0.991 (0.860, 1.142) | 0.899 | 0.115 | 0.117 |
 Chronic myeloid leukemia | 0.889 (0.757, 1.043) | 0.149 | 0.624 | 0.633 | 0.921 (0.747, 1.134) | 0.438 | 0.305 | 0.307 |
 Chronic lymphocytic leukemia | 0.981 (0.891, 1.080) | 0.697 | 0.004 | 0.006 | 0.967 (0.872, 1.073) | 0.528 | 0.793 | 0.791 |
Genital system | ||||||||
 Ovary | 0.951 (0.892, 1.015) | 0.132 | 0.216 | 0.211 | 0.983 (0.909, 1.063) | 0.661 | 0.522 | 0.511 |
 Uterine cervix | 1.043 (0.920, 1.184) | 0.510 | 0.545 | 0.546 | 0.978 (0.834, 1.147) | 0.786 | 0.808 | 0.807 |
 Uterine corpus | 0.989 (0.928, 1.053) | 0.723 | 0.004 | 0.005 | 0.954 (0.885, 1.028) | 0.216 | 0.114 | 0.105 |
 Vulva | 1.142 (0.947, 1.377) | 0.165 | 0.336 | 0.351 | 0.864 (0.673, 1.109) | 0.251 | 0.118 | 0.124 |
 Testis | 1.040 (0.939, 1.151) | 0.451 | 0.996 | 0.997 | 0.983 (0.864, 1.117) | 0.790 | 0.998 | 0.999 |
 Prostate | 0.998 (0.973, 1.024) | 0.902 | 0.441 | 0.443 | 1.012 (0.973, 1.052) | 0.543 |  < 0.001 | 0.001 |
Breast | 1.008 (0.958, 1.061) | 0.691 | 0.980 | 0.961 | 1.013 (0.955, 1.074) | 0.675 | 0.692 | 0.697 |
Skin cancer | ||||||||
 Malignant melanoma | 1.024 (0.978, 1.072) | 0.305 | 0.038 | 0.039 | 1.009 (0.953, 1.069) | 0.749 | 0.087 | 0.084 |
 Malignant nonmelanoma | 1.041 (1.009, 1.075) | 0.012 |  < 0.001 |  < 0.001 | 1.012 (0.985, 1.039) | 0.392 |  < 0.001 |  < 0.001 |
Other | ||||||||
 Eye and annexa | 1.120 (0.978, 1.296) | 0.129 | 0.561 | 0.564 | 1.092 (0.908, 1.312) | 0.350 | 0.557 | 0.556 |
 Kidney | 1.033 (0.975, 1.095) | 0.274 | 0.500 | 0.510 | 1.011 (0.937, 1.092) | 0.773 | 0.234 | 0.250 |
 Bladder | 1.008 (0.965, 1.053) | 0.724 | 0.214 | 0.211 | 0.979 (0.925, 1.035) | 0.453 | 0.151 | 0.160 |
 Bone | 1.062 (0.905, 1.245) | 0.460 | 0.978 | 0.987 | 0.900 (0.736, 1.100) | 0.304 | 0.910 | 0.908 |
 Brain | 1.105 (1.013, 1.205) | 0.024 | 0.124 | 0.144 | 1.081 (0.975, 1.198) | 0.137 | 0.490 | 0.474 |
 Thyroid | 1.005 (0.907, 1.112) | 0.930 | 0.713 | 0.736 | 0.958 (0.841, 1.091) | 0.514 | 0.403 | 0.413 |